ICD-10 Coding for Small Cell Carcinoma(C34.31U, C34.32, C34.32B)
Learn about ICD-10 coding for small cell carcinoma, including primary and metastatic codes, documentation requirements, and common pitfalls.
Complete code families applicable to Small Cell Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.92 | Malignant neoplasm of unspecified part of unspecified bronchus or lung | Use when small cell carcinoma is confirmed but specific site or laterality is not documented. |
|
| C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung | Use when small cell carcinoma is confirmed in the left lower lobe. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutSmall Cell Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Small Cell Carcinoma.
Using C34.9X without specifying laterality
Impact
Clinical: May lead to inappropriate treatment planning., Regulatory: Non-compliance with ICD-10 coding standards., Financial: Potential for denied claims or reduced reimbursement.
Mitigation
Ensure laterality is documented in all clinical notes., Cross-check imaging reports for laterality.
Coding unspecified site when specific site is documented
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation
Review all clinical documentation for specific site information.
Unspecified site coding
Impact
Coding without specific site documentation increases audit risk.
Mitigation
Implement mandatory documentation checks for site and laterality.